Antitussive

Sneezing, Chronic Pain, Catarrh + 31 more
Treatment
1 FDA approval
20 Active Studies for Antitussive

What is Antitussive

PseudoephedrineThe Generic name of this drug
Treatment SummaryDextromethorphan is a medication used to suppress coughing. It is similar in structure to other opioids, but it has a limited effect on opioid receptors. It was approved by the FDA in 1957 and can be found in many over-the-counter cold and cough medications.
Nasal Decongestant Maximum Strengthis the brand name
Antitussive Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Nasal Decongestant Maximum Strength
Pseudoephedrine
1981
547

Approved as Treatment by the FDA

Pseudoephedrine, also known as Nasal Decongestant Maximum Strength, is approved by the FDA for 1 uses including Nasal Congestion .
Nasal Congestion

Effectiveness

How Antitussive Affects PatientsDextromethorphan is a drug used in combination with other medications to treat coughing and a condition called pseudobulbar affect. It is important to take the proper dose, as taking too much can cause intoxication. The effects of Dextromethorphan last for a moderate amount of time, so patients should be aware of the potential risks.
How Antitussive works in the bodyDextromethorphan works by interacting with certain receptors in the body. It stimulates some receptors, like NMDA and sigma-1, while blocking others, like alpha3/beta4 nicotinic receptors. We don't know exactly how this translates to a clinical effect.

When to interrupt dosage

The measure of Antitussive is contingent upon the recognized condition, including Coughing, Fever and Antisepsis. The dosage changes as per the technique of administration depicted in the table beneath.
Condition
Dosage
Administration
Common Cold
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Rhinorrhea
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Sinus Congestion
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Coughing
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Hypersensitivity
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Common Cold
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Eye
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Sneezing
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Chronic Pain
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Catarrh
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Priapism
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Acute Bronchitis
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Throat irritation
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Migraine
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Sinusitis
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Upper respiratory tract congestion
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Bronchitis
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Fever
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Upper respiratory tract signs and symptoms
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension
Pharyngitis
60.0 mg, , 120.0 mg, 240.0 mg, 30.0 mg, 6.0 mg/mL, 3.0 mg/mL, 15.0 mg/mL, 30.0 mg/mL, 60.0 mg/mL, 10.0 mg/mL, 20.0 mg/mL, 40.0 mg, 50.0 mg/mL, 14.998 mg/mL, 15.001 mg/mL, 0.3 mg/mg, 0.15 mg/mg, 7.5 mg/mL, 25.0 mg, 45.0 mg/mL, 15.0 mg, 7.5 mg, 9.38 mg/mL, 20.0 mg, 45.0 mg, 4.0 mg/mL, 80.0 mg, 4.5 mg/mL, 22.5 mg/mL, 14.999 mg/mL, 9.0 mg/mL, 8.0 mg/mL, 12.5 mg/mL, 25.0 mg/mL, 180.0 mg, 0.6 mg/mg, 75.0 mg/mL, 0.06 mg/mg, 0.006 mg/mg
Oral, Powder, for solution - Oral, , Powder, for solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, film coated - Oral, Tablet, film coated, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Capsule, liquid filled - Oral, Capsule, liquid filled, Tablet, coated, Liquid - Oral, Tablet, coated - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Syrup - Oral, Syrup, Elixir - Oral, Elixir, Solution / drops, Solution / drops - Oral, Capsule, Capsule - Oral, Suspension - Oral, Suspension, Pill, Pill - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Powder, Powder - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Kit; Tablet - Oral, Kit; Tablet, Tablet; Tablet, extended release - Oral, Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule; Kit - Oral, Capsule; Kit, Kit; Powder - Oral, Kit; Powder, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Kit; Powder, for solution, Kit, Kit - Oral, Solution / drops - Nasal, Nasal, Tablet, for suspension - Oral, Tablet, for suspension

Warnings

Antitussive has one contraindication indicating that it should not be taken if the conditions in the following table are present.Antitussive Contraindications
Condition
Risk Level
Notes
Coronary Artery Disease
Do Not Combine
Hypertension
Do Not Combine
Urinary Retention
Do Not Combine
Pulse Frequency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Pseudoephedrine may interact with Pulse Frequency
There are 20 known major drug interactions with Antitussive.
Common Antitussive Drug Interactions
Drug Name
Risk Level
Description
Iobenguane
Major
Pseudoephedrine can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylene blue
Major
Pseudoephedrine may increase the serotonergic activities of Methylene blue.
Mirtazapine
Major
Pseudoephedrine may increase the serotonergic activities of Mirtazapine.
1-benzylimidazole
Minor
The therapeutic efficacy of 1-benzylimidazole can be decreased when used in combination with Pseudoephedrine.
4-Methoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Pseudoephedrine is combined with 4-Methoxyamphetamine.
Antitussive Toxicity & Overdose RiskTaking too much dextromethorphan can cause nausea, vomiting, loss of consciousness, difficulty breathing, seizures, rapid heartbeat, excitability, mental confusion, lack of coordination, blurred vision, changes in muscle reflexes, and a serotonin overload. Treatment for an overdose should focus on relieving the symptoms and providing support.
image of a doctor in a lab doing drug, clinical research

Antitussive Novel Uses: Which Conditions Have a Clinical Trial Featuring Antitussive?

134 active studies are presently assessing the suitability of Antitussive for Influenza, Pseudobulbar Affect (PBA) and Coughing alleviation.
Condition
Clinical Trials
Trial Phases
Sinus Congestion
0 Actively Recruiting
Chronic Pain
129 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1
Throat irritation
0 Actively Recruiting
Hypersensitivity
1 Actively Recruiting
Phase 4
Acute Bronchitis
7 Actively Recruiting
Phase 4, Not Applicable, Phase 3, Early Phase 1
Sneezing
0 Actively Recruiting
Migraine
13 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4
Pharyngitis
0 Actively Recruiting
Bronchitis
0 Actively Recruiting
Sinusitis
2 Actively Recruiting
Not Applicable
Influenza
29 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3
Hay Fever
0 Actively Recruiting
Rhinorrhea
0 Actively Recruiting
Seasonal Allergies
0 Actively Recruiting
Fever
2 Actively Recruiting
Not Applicable, Phase 4
Perennial Allergy
0 Actively Recruiting
Coughing
0 Actively Recruiting
Common Cold
0 Actively Recruiting
Eye
0 Actively Recruiting
Coughing
0 Actively Recruiting

Antitussive Reviews: What are patients saying about Antitussive?

4Patient Review
11/5/2009
Antitussive for Cough
I did feel a sense of euphoria while taking this medication, which could be addicting for some. Be mindful of that possibility if you decide to try it.
3.3Patient Review
2/4/2015
Antitussive for Cough
I started having hearing problems on the third day. It's possible that this medication is affecting my hearing power. So far, the only other side effect I've noticed is an allergic reaction.

Patient Q&A Section about antitussive

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is antitussive good for dry cough?

"Expectorants thin mucus and help your cough move it out. This works best for productive coughs caused by colds or allergies.

Cough suppressants stop your cough by making it harder for your brain to tell your body to cough. Expectorants make it easier to cough up mucus by thinning it out."

Answered by AI

What is an example of an antitussive?

"Antitussives that can be bought without a prescription and that work on the central nervous system include dextromethorphan products (Delsym, Robitussin, Vicks Formula 44, and Triaminic)."

Answered by AI

Which drug is antitussive drug?

"Guaifenesin is a medication used to thin mucus and make coughs more productive. It is commonly used to treat conditions such as the common cold, bronchitis, and other breathing illnesses."

Answered by AI

What is the most effective antitussive?

"The most effective antitussive agents are opioids. These drugs most likely act both on brainstem opioid receptors and on receptors located peripherally on sensory nerve endings in the airways."

Answered by AI

Clinical Trials for Antitussive

Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Have you considered Antitussive clinical trials? We made a collection of clinical trials featuring Antitussive, we think they might fit your search criteria.Go to Trials
Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD
Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.
Phase 2
Waitlist Available
National Institutes of Health Clinical Center (+1 Sites)Luca T Giurgea, M.D.
Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN
This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?
Phase 2
Recruiting
Vanderbilt University Medical CenterNatahsa Halasa, MD, MPH
Have you considered Antitussive clinical trials? We made a collection of clinical trials featuring Antitussive, we think they might fit your search criteria.Go to Trials
Image of Altasciences Inc - Kansas City in Overland Park, United States.

VNT-101 for Safety and Tolerability Study

18 - 59
All Sexes
Overland Park, KS
A randomized, double-blind, placebo-controlled Phase 1 study conducted at a single center with approximately 78 healthy adults aged 18-59 years. Part 1 Single Ascending Dose (SAD) will enroll 48 participants into six cohorts (S1-S6) to receive single oral doses of VNT-101 (100-1500 mg) or placebo under fasting or fed (S5 only) conditions. Part 2 Multiple Ascending Dose (MAD) will enroll 30 participants into three cohorts (M1-M3) to receive multiple oral doses of VNT-101 (250-750 mg BID Days 1-5, QD Day 6) or placebo under fasting conditions. Dose escalation in both parts will proceed after Protocol Safety Review Team (PSRT) review. The primary objective for Part 1 is to evaluate the safety and tolerability of single ascending oral (SAD) doses of VNT-101 in healthy adult participants under either fasting or fed conditions. The primary objective for part 2 is to evaluate the safety and tolerability of multiple ascending oral (MAD) doses of VNT-101 in healthy adult participants.
Phase 1
Recruiting
Altasciences Inc - Kansas City
Have you considered Antitussive clinical trials? We made a collection of clinical trials featuring Antitussive, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security